Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-02-27The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-02-24A Two-Part Study Designed to Evaluate the Pharmacokinetic Profile of MIN-101 and Its Main Metabolites Following Single and Multiple Dose Modified Release Prototype Formulation Administration in Healthy Cytochrome P450 2D6 Extensive Metabolizer Male and Female Subjects, and to Evaluate the Relationship Between the Pharmacokinetic Profile of MIN-101 and Its Main Metabolites and Cardiovascular Parameters.
-
CLINICAL_TRIALS study record update · 2015-02-19A Phase 1, Randomized, Placebo- Controlled, Double-Blind Safety, Tolerability, Pharmacokinetic, and Exploratory Pharmacodynamic Study in Healthy Subjects and Subjects With Stable Schizophrenia After Multiple Doses of ITI-214
-
CLINICAL_TRIALS study record update · 2015-02-19Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems
-
CLINICAL_TRIALS study record update · 2015-02-18Short-Term Response of Serum Brain-Derived Neurotrophic Factor to Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-02-18Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods.
-
CLINICAL_TRIALS study record update · 2015-02-18Interventional, Randomised, Double-blind, Placebo Controlled, Multiple-dose Study Investigating the Safety, Tolerability, PK and PD Properties of Lu AF11167 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-02-18A 24-month, Prospective, Randomized, Active-Controlled, Open-Label, Rater-Blinded, Multicenter, International Study of the Prevention of Relapse Comparing Long-Acting Injectable Paliperidone Palmitate to Treatment as Usual With Oral Antipsychotic Monotherapy in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-02-16A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-02-05Exploration of Neural Bases in Social Cognition
-
CLINICAL_TRIALS study record update · 2015-02-04Double Blind Study of Estradiol Plus Neuroleptic Versus Placebo Plus Neuroleptic in the Treatment of Psychotic Symptoms in Women With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-02-04Evaluation of an Intervention Program Designed to Improve Understanding of Irony on the Hemispheric Processing of Ambiguous Figurative Language in Adults With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-01-30Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia?
-
CLINICAL_TRIALS study record update · 2015-01-22The Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia - A Prospective Open-Label Multicenter Study
-
CLINICAL_TRIALS study record update · 2015-01-16A Single-center Safety and Tolerability Study to Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2015-01-16Nicotine Effects on Endophenotypes of Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-01-16A Randomized, Double-Blind, Placebo-Controlled, Twice Daily Titration Study of the Safety and Tolerability of Bifeprunox in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2015-01-16A Randomized, Double-Blind, Placebo-Controlled, Sequential Panel Study of the Safety and Tolerability of Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Either Schizophrenia or Bipolar Disorder With an Optional Open-Label 26-Week Extension Study
-
CLINICAL_TRIALS study record update · 2015-01-16A Randomized, Double-Blind, Olanzapine-Referenced, Parallel-Group Safety and Efficacy Study of Flexible Doses of Bifeprunox in the Long-term Treatment of Schizpohrenia (Extension of S1543003)
-
CLINICAL_TRIALS study record update · 2015-01-12A Double-Blind, Escalating Dose Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Repeat Doses of EVP-6308 or Placebo in Subjects With Schizophrenia on a Stable Antipsychotic Regimen
-
CLINICAL_TRIALS study record update · 2015-01-08Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI
-
CLINICAL_TRIALS study record update · 2015-01-08Promoting Health and Functioning in Persons With SMI
-
CLINICAL_TRIALS study record update · 2014-12-24Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
-
CLINICAL_TRIALS study record update · 2014-12-23Patient-Centered Medication Adherence Intervention for Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-12-17A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents With Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia